Cision PR Newswire

Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO

Median OS was extended by 8.5 months compared with platinum-based doublet chemotherapy (25.9 vs 17.4 months), with a 31% reduction in the risk...

WePlay Teams Up with CHIBI MARUKO-CHAN to Celebrate Its Fourth Anniversary!

TOKYO, Sept. 15, 2025 /PRNewswire/ -- The highly popular social entertainment app WePlay announced today that, to express gratitude for users' longstanding support, it has...

Home Control (1747.HK) Announces Strategic Expansion into Healthcare Sector; Leveraging multi-disciplinary technologies which might include AIoT, Web3, expecting a potential increase in valuation

HONG KONG, Sept. 15, 2025 /PRNewswire/ -- On 12 September, Home Control (1747.HK) announced a strategic expansion into the healthcare sector with plans to...

FOMO Group Welcomes SGX Group to Capital Table As Shareholder, Expanding Its Blue-Chip Investor Base

SINGAPORE, Sept. 15, 2025 /PRNewswire/ -- FOMO Group, a leading fintech group headquartered in Singapore, today announced that SGX Group (Singapore Exchange), Asia's leading...